KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Divestments (2021 - 2025)

Evolent Health (EVH) has 5 years of Divestments data on record, last reported at $198000.0 in Q3 2025.

  • For Q3 2025, Divestments changed N/A year-over-year to $198000.0; the TTM value through Dec 2025 reached $198000.0, up 2728.57%, while the annual FY2025 figure was $986000.0, 13985.71% up from the prior year.
  • Divestments reached $198000.0 in Q3 2025 per EVH's latest filing, up from $7000.0 in the prior quarter.
  • Across five years, Divestments topped out at $43.0 million in Q1 2021 and bottomed at -$28.8 million in Q3 2021.
  • Average Divestments over 5 years is $6.3 million, with a median of $492000.0 recorded in 2023.
  • The widest YoY moves for Divestments: up 100.38% in 2023, down 99.94% in 2023.
  • A 5-year view of Divestments shows it stood at $28.8 million in 2021, then decreased by 6.89% to $26.8 million in 2022, then crashed by 99.74% to $71000.0 in 2023, then plummeted by 90.14% to $7000.0 in 2024, then soared by 2728.57% to $198000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Divestments were $198000.0 in Q3 2025, $7000.0 in Q2 2024, and $71000.0 in Q3 2023.